Overview Financials News + Filings
|
|
Dermavant Sciences Ltd
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Mar-31-19 | Mar-31-18 |
| | Source | Source |
| Turnover Ratios |
| Asset turnover | 14.2 | |
| |
| Returns on Capital |
| ROIC (including intangibles) | 1741.0% | 571.9% |
| ROE | 240.4% | -481.5% |
| ROA | -1413.4% | -246.0% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 |
|